paclitaxel has been researched along with Adenocarcinoma, Papillary in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.41) | 18.2507 |
| 2000's | 14 (51.85) | 29.6817 |
| 2010's | 11 (40.74) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devi, S; Fatima, R; Jagadish, N; Kumar, V; Sharma, A; Suri, A; Suri, V | 1 |
| Baratti, D; Deraco, M; Guaglio, M; Kusamura, S; Nizri, E; Rajendra, VJ; Salcedo-Hernández, RA; Sinukumar, S | 1 |
| Cao, YC; Geng, M; Li, PF; Wang, L; Yin, YC | 1 |
| Li, Y; Shang, YM; Yang, Y; Zheng, H | 1 |
| Bishr, AM; Deme, D; Nizar, J; Telekes, A | 1 |
| Barakova, NV; Bespalov, VG; Maidin, MA; Semenov, AL; Stukov, AN; Vasil'eva, IN; Vyshinskaya, EA | 1 |
| Abu-Rustum, NR; Bains, M; Huang, M; Levine, DA; Rizk, N | 1 |
| Bair, SM; Cherpelis, BS; Fenske, NA; Glass, LF; Marquez, CB; Smithberger, EE; Wenham, RM | 1 |
| Ebina, Y; Hosaka, M; Mitamura, T; Moriwaki, M; Ohba, Y; Sakuragi, N; Takeda, M; Todo, Y; Watari, H | 1 |
| de la Peña, FA; Garcia-Martinez, E; Vicente, E; Zafra, M | 1 |
| Blagden, S; Gabra, H; Graham, J; Sharma, R | 1 |
| Beriwal, S; Edwards, RP; Krivak, TC; Lesnock, JL; McBee, WC; Richard, SD; Skaznik-Wikiel, ME; Zorn, KK | 1 |
| Baird, RD; Barton, DP; Kaye, SB; Khan, AZ; Moreno, V; Vitfell-Pedersen, J; Yap, TA | 1 |
| Aruga, T; Honda, Y; Horiguchi, K; Kitagawa, D; Kuroi, K; Nako, Y; Shigekawa, T; Yamashita, T | 1 |
| Anastasia, P | 1 |
| Chapman, J; Drisko, JA; Hunter, VJ | 1 |
| Balat, O; Ugur, MG | 1 |
| Arimoto-Ishida, E; Kimura, A; Mabuchi, S; Murata, Y; Nishio, Y; Ohmichi, M; Tasaka, K; Yada-Hashimoto, N | 1 |
| Hirai, I; Honda, K; Kokawa, Y; Okamura, Y; Oura, S; Sasaki, R; Yoshimasu, T | 1 |
| Atabekoglu, C; Berker, B; Bilgin, T; Dunder, I | 1 |
| Akizuki, S; Andoh, M; Fujiwara, Y; Katsumata, N; Watanabe, T; Yamanaka, Y | 1 |
| Chao, TJ; Chen, FM; Ko, TL; Kuo, TC; Li, YT | 1 |
| Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC | 1 |
| Cameron, MR; Caudle, MR; Peluso, JJ; Sullivan, WR; Wimalasena, J | 1 |
| Loizzi, P; Nappi, L; Nappi, R; Resta, L | 1 |
| Arimoto, Y; Hayashi, S; Komura, H; Kunishige, I; Okuno, Y; Otsuki, Y; Shimoya, K | 1 |
| Newton, HB; Santi, M; Stevens, C | 1 |
3 trial(s) available for paclitaxel and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Drug Administration Schedule; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel | 2008 |
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome | 2011 |
Preliminary experience with salvage weekly paclitaxel in women with advanced recurrent ovarian carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Carcinoma, Endometrioid; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Radiography; Salvage Therapy; Survival Analysis; Treatment Outcome; Turkey | 2005 |
24 other study(ies) available for paclitaxel and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma, Papillary; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Injections, Intralesional; Mice, Nude; Molecular Targeted Therapy; Neoplasm Proteins; Ovarian Neoplasms; Paclitaxel; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2018 |
Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institut
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytoreduction Surgical Procedures; Doxorubicin; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Length of Stay; Middle Aged; Neoadjuvant Therapy; Neoplasms, Cystic, Mucinous, and Serous; Paclitaxel; Peritoneal Neoplasms; Peritoneum; Postoperative Complications; Progression-Free Survival; Retrospective Studies | 2019 |
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Signet Ring Cell; Case-Control Studies; Cell Differentiation; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Situ Hybridization; Mitomycin; Neoplasm Grading; Paclitaxel; RNA, Messenger; Stomach Neoplasms; Telomerase; Tumor Cells, Cultured | 2013 |
Bevacizumab combined with chemotherapy in the treatment of recurrence or platinum-refractory ovarian cancer: a retrospective study of 37 cases.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Transitional Cell; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2014 |
[Individualized therapy of synchronous ovarian and colon cancers with lymph].
Topics: Abdominal Pain; Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Administration Schedule; Female; Fever; Fluorouracil; Humans; Immunohistochemistry; Keratin-20; Keratin-7; Laparotomy; Leucovorin; Lymphatic Metastasis; Neoplasms, Multiple Primary; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Precision Medicine; Treatment Outcome | 2015 |
Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer.
Topics: Adenocarcinoma, Papillary; Animals; Antineoplastic Agents; Ascites; Cisplatin; Female; Injections, Intraperitoneal; Injections, Intravenous; Melphalan; Mitomycin; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Rats; Survival Analysis; Treatment Outcome; Triazines | 2017 |
Intra-thoracic cytoreduction of stage IV peritoneal malignancy: a case series.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Diaphragm; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Peritoneal Neoplasms | 2008 |
Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene.
Topics: Adenocarcinoma, Papillary; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bexarotene; Carboplatin; Clinical Trials as Topic; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Female; Humans; Hypertriglyceridemia; Hypothyroidism; Keratoacanthoma; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Ovarian Neoplasms; Paclitaxel; Phenylurea Compounds; Pyridines; Skin Diseases; Sorafenib; Tetrahydronaphthalenes | 2009 |
Acute rhabdomyolysis as a complication of paclitaxel-gemcitabine chemotherapy for ovarian cancer.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Rhabdomyolysis | 2009 |
Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Pennsylvania; Registries; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials.
Topics: Adenocarcinoma, Papillary; Adult; Afatinib; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Ovarian Neoplasms; Paclitaxel; Pelvic Neoplasms; Phthalazines; Piperazines; Quinazolines; Uterine Cervical Neoplasms | 2012 |
[A case of primary breast cancer responding to pre-operative chemotherapy with the combination of paclitaxel and carboplatin for ovarian cancer].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Sentinel Lymph Node Biopsy | 2012 |
Intraperitoneal chemotherapy for ovarian cancer.
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Oncology Nursing; Ovarian Neoplasms; Paclitaxel | 2012 |
The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carboplatin; Complementary Therapies; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Treatment Outcome; Vitamins | 2003 |
Prolonged stabilization of platinum/paclitaxel-refractory ovarian cancer with topotecan: a case report and review of the literature.
Topics: Adenocarcinoma, Papillary; Agranulocytosis; Drug Resistance, Neoplasm; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Quality of Life; Topotecan | 2003 |
Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Estrogens; Female; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Paclitaxel; Phosphorylation; Receptors, Estrogen; Serine | 2004 |
[Successful management of malignant pericardial effusion with weekly paclitaxel therapy in a lung adenocarcinoma patient].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Kidney Failure, Chronic; Lung Neoplasms; Paclitaxel; Pericardial Effusion | 2003 |
Weekly paclitaxel in patients with CAP-resistant advanced or recurrent endometrial carcinoma: a series of four patients.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Doxorubicin; Drug Resistance, Neoplasm; Feasibility Studies; Female; Humans; Infusions, Intravenous; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Survival Rate; Treatment Outcome | 2005 |
Treatment of an advanced ovarian cancer patient receiving hemodialysis.
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Carboplatin; Dose-Response Relationship, Drug; Female; Humans; Nephritis; Ovarian Neoplasms; Paclitaxel; Renal Dialysis | 2007 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Signet Ring Cell; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Paclitaxel; RNA, Messenger; Stomach Neoplasms; Telomerase | 2007 |
The steroidogenic and morphological effects of paclitaxel on cultured ovarian cancer cells.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Aromatase; Colchicine; Estradiol; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured | 1995 |
Primary carcinoma of the fallopian tube: report on two cases.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; CA-125 Antigen; Cisplatin; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Paclitaxel | 1996 |
[A case of papillary adenocarcinoma of the ovary that responded favorably to irinotecan hydrochloride and cisplatin after the administration of paclitaxel and carboplatin].
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Carboplatin; Cisplatin; Cyclophosphamide; Female; Humans; Irinotecan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Treatment Outcome | 2001 |
Brain metastases from fallopian tube carcinoma responsive to intra-arterial carboplatin and intravenous etoposide: a case report.
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem; Carboplatin; Carotid Arteries; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Etoposide; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Physical Examination; Rupture, Spontaneous; Temozolomide; Temporal Lobe; Vertebral Artery | 2001 |